Profil
Marek Ciszewski currently works at Aravive, Inc., as Vice President-Investor Relations.
Mr. Ciszewski also formerly worked at Lantern Pharma, Inc., as Director-Investor Relations from 2020 to 2021, BMO Harris Bank, NA (Investment Management), as Senior Equity Analyst, VC Units Co. LLC, as Research Analyst from 1998 to 2007, Whitestone REIT, as Head-Investor Relations, Perritt Capital Management, Inc., as Analyst, Harris Investment Management, Inc., as Vice President, On Line Capital Advisors LLC, as Analyst, Nesbitt Burns, Inc., as Principal, Smith Barney & Co., Inc., as Principal, and EPIRUS Biopharmaceuticals, Inc., as Head-Investor Relations.
Mr. Ciszewski received his graduate degree in 2002 from Illinois Institute of Technology and undergraduate degree in 1995 from DePaul University.
Postes actifs de Marek Ciszewski
| Sociétés | Poste | Début |
|---|---|---|
| ARAVIVE, INC. | Investor Relations Contact | - |
Anciens postes connus de Marek Ciszewski
| Sociétés | Poste | Fin |
|---|---|---|
| LANTERN PHARMA INC. | Investor Relations Contact | 01/05/2021 |
VC Units Co. LLC
VC Units Co. LLC Investment ManagersFinance Provides investment advisory services | Analyst-Equity | 30/11/2007 |
| WHITESTONE REIT | Investor Relations Contact | - |
| EPIRUS BIOPHARMACEUTICALS, INC. | Investor Relations Contact | - |
Smith Barney & Co., Inc.
Smith Barney & Co., Inc. Investment Banks/BrokersFinance Provides securities brokerage services | Corporate Officer/Principal | - |
Formation de Marek Ciszewski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
BMO Bank NA (Investment Management)
BMO Bank NA (Investment Management) Investment ManagersFinance BMO-IM manages a variety of fixed-income and dividend-yielding equities. The firm's investment strategy focuses on asset allocation, but they also believe that substantial value is created by making disciplined, research-driven tactical asset allocation adjustments to capture market opportunities as they arise. BMO-IM employs a disciplined, multi-step process to create customized portfolios for each client. The firm defines the client's investment objectives, establishes the client's strategic asset allocation strategy, and implements tactical asset allocation, portfolio construction, and portfolio management. | Finance |
VC Units Co. LLC
VC Units Co. LLC Investment ManagersFinance Provides investment advisory services | Finance |
Whitestone REIT
Whitestone REIT Real Estate Investment TrustsFinance Operates as a real estate investment trust which invests in retail properties | Finance |
Perritt Capital Management, Inc.
Perritt Capital Management, Inc. Investment ManagersFinance PCM uses an investment philosophy that combines their long-term investment horizon with a fundamental understanding that a well-balanced and diversified portfolio can help clients further achieve their investment goals and satisfy their risk tolerance. | Finance |
Harris Investment Management, Inc.
Harris Investment Management, Inc. Investment ManagersFinance Provides investment advice | Finance |
Illinois Institute of Technology
Illinois Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
On Line Capital Advisors LLC
On Line Capital Advisors LLC Investment ManagersFinance Investment advisory firm | Finance |
Nesbitt Burns, Inc.
Nesbitt Burns, Inc. Investment ManagersFinance Investment management | Finance |
DePaul University
DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Smith Barney & Co., Inc.
Smith Barney & Co., Inc. Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
EPIRUS Biopharmaceuticals, Inc.
EPIRUS Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biosimilar monoclonal antibodies | Health Technology |
Lantern Pharma, Inc.
Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
Aravive, Inc.
Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
















